Finn's Take· TL;DRShares of the world's largest humanoid robot maker by sales, Unitree, jumped more than 600% in its trading debut in Shanghai on Wednesday, in a testament to its status as the poster child of China's robotic advancement. To put that in perspective: an investor who bought shares at the IPO price watched their money multiply sevenfold in a single day. It was the kind of debut that makes financial history.
On its debut on August 20, the company's stock spiked as much as 629% to 1,100 yuan at the open, compared with its offering price of 150.80 yuan, before paring some gains to close at 845 yuan, up 460%. Unitree raised 6.1 billion yuan ($905 million) in its initial public offering, which was oversubscribed more than 8,000 times — a record for Shanghai's tech-focused STAR Market, widely seen as China's version of the Nasdaq.
The Unitree IPO instantly became a proxy for investor appetite in China's booming robotics sector, with retail traders piling into a company whose machines have already gone viral for backflips, martial arts routines, and dance performances alongside pop stars. Unitree had previously drawn significant attention during China's annual Spring Festival gala, with its dexterous robots wearing traditional Chinese vests and performing kung fu while jumping over tables.
According to the company's prospectus, revenue more than quadrupled to 1.7 billion yuan in 2025, and humanoid robot sales reached 867.8 million yuan, overtaking the quadruped robots that first made the company well known. Crucially, Unitree stands out because it is already profitable — a rarity in the world of humanoid robotics. It shipped more than 5,500 humanoids in 2025 and around 18,000 units across its full range by July 2026.
Just days before the listing, Unitree unveiled a new humanoid robot called "Superman," touting it as able to jump as high as two metres and run as fast as 12.66 metres per second — faster than world record-holder Usain Bolt, if sustained over 100 metres. The timing was no accident. The IPO coincided with the opening day of the World Robot Conference in Beijing, where Unitree's booth was swarmed by dozens of visitors and reporters.
In a regulatory filing, Unitree disclosed that retail investors faced odds of approximately 0.018% of receiving shares, following a partial reallocation away from the institutional portion of the deal. That means the average person trying to get in on the ground floor had almost no chance. One global strategist called it "the market firing a flare gun over China's next speculative frontier," adding that "the message is pretty clear: embodied AI has become the new object of desire."
The IPO valued the company at roughly $53 billion after raising $904 million, with a price-to-earnings ratio nearing 1,300 times. That massive valuation dwarfs U.S. counterpart Agility Robotics, which is going public via SPAC at an implied $4 billion. China has rapidly emerged as the global leader in humanoid robot manufacturing, producing virtually all of the world's supply last year.
Unitree's products are used not just by domestic academics, but also by U.S. tech giants such as Nvidia, Google, and Amazon. Still, the commercial reality remains grounded. Research and educational institution use accounts for the majority of Unitree's sales, while industrial deployments remained less than 10% in the first three quarters of 2025.
As one equity analyst at Morningstar noted, "Unitree has demonstrated strong technology and commercial traction, but moving from demonstrations and early deployments to widespread industrial adoption will take time." Unitree's debut is the first real public-market pricing on a pure-play humanoid robot company — and now it has set a benchmark that every private round, SPAC, and robotics startup board deck can be compared to. Whether the extraordinary investor enthusiasm reflects a genuine technological revolution or a speculative bubble, one thing is clear: the age of the humanoid robot has officially arrived on Wall Street's global stage.